VMS Asset Management
VC Fund
Hong Kong, Hong Kong
VMS Asset Management is a VC fund in Hong Kong focused on Biotechnology and Health Care. VMS Group was established in 2006. For the past 15 years, VMS Group has grown to become a leading multi-strategy financial group providing individual, corporate and institutional investors with investment solutions as well as securities brokerage and corporate finance advisory services. Licensed with the Hong Kong Securities and FuturesCommission (HK SFC) to carry on business in Type 9 (Asset Management) Regulated Activity, VMS Asset Management is an asset management subsidiary of VMS Group, specializing investments in Private Equity, Real Estate and Structured Finance. Our private equity focuses on growth-stage companies in the Healthcare, Tech (including New Economy and Deep Tech) and Media sectors with visionary founders, proven track records, capable human capital and unique business models. In addition to our sector expertise, our strategic partners, portfolio companies and collaboration with some of the best-in-class global PE funds set us apart from the competition. In real estate, we have solid project investment, advisory and financing capabilities through our unique market positioning and close working relationships with a broad range of Chinese property companies. For structured finance, our edge lies in our strong deal origination ability and bespoke financing solution structuring skills.Leveraging on an extensive global network and in-depth local knowledge, VMS Group has successfully completed more than 100 investments both onshore in China and offshore around the world. Headquartered in Hong Kong with more than 80 staff, out of that over 30 are investment professionals, VMS Group currently has in excess of USD 3.8 billion assets under management.
- Total investments:
- 40
- Last investment:
- Lead investor:
- 30%
Last updated:
For AI agents: llms.txt
Industries VMS Asset Management invests in
Stages VMS Asset Management invests in
Countries VMS Asset Management invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $8M–$1.5B
- Series B
- $16M–$80M
- Series C
- $15M–$100M
Investment Focus
Industry
- Biotechnology 12 (30%)
- Health Care 10 (25%)
- Big Data 5 (13%)
- Pharmaceutical 5 (13%)
- Internet 4 (10%)
Stage
- Series C 11 (28%)
- Series A 7 (18%)
- Series B 6 (15%)
- Series E 3 (8%)
- Private Equity 3 (8%)
Country
- China 26 (65%)
- United States 8 (20%)
- Egypt 1 (3%)
- Israel 1 (3%)
- Taiwan 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Wu Zhaowei
Partner
|
Partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Making computing more human and effortless. Sensor based position tracking technology using a patented permanent magnet approach. | Series A / Aug 07, 2026 | ||
| Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases. | $28.1M / Series B / Feb 07, 2024 | ||
| Awfar Market is the first online platform for supermarket and Grocery Stores in MENA Region, providing users with the ability to choose their favorite supermarket chain and shop for groceries, also comparing and viewing products nutrition information and picking appropriate delivery time & method of payment. Awfar Market provided the deliveryy service in the most safe and hygienic way through Through our Cloud Sourcing Delivery Application, Delivery Rep ( with their cars ) using our Application to pickup order and deliver to customer GPS Location, which is equipped with the required tools to keep your groceries safe, cool and fresh.- Vision Our Vision to be a leader in the e-commerce Sector In Middle east Through building a new shopping experience matching with culture of Middle East customers and satisfy their needs.- Mission: We are on a mission to virtualize the businesses around the Arab world | $405K / Seed / Feb 05, 2023 | ||
| CiDi is a smart and intelligent automotive technology research and development company. | $45M / Series C / May 06, 2022 | ||
| Laiye is a digital workforce platform that empowers organizations by integrating AI Agents to boost employee productivity and creativity. The platform combines various intelligent automation capabilities, including RPA and IDP, to streamline operations and enhance business outcomes. | $70M / Series C / Apr 18, 2022 | ||
| Slope is a community-based decentralized exchange built on Solana. | $8M / Series A / Feb 24, 2022 | ||
| Uniskin is a cosmetics brand that provides skin-care products suitable for the local area and people. | $15.7M / Series B / Dec 01, 2021 | ||
| SyMap is dedicated to developing a proprietary, catheter-based renal mapping and ablation system for renal denervation therapy to treat hypertension and other diseases, such as heart failure, arrhythmia, and renal failure. | $100M / Series E / Dec 01, 2021 | ||
| HAI ROBOTICS creates and delivers value to every warehouse and factory with advanced robotics and AI algorithm. The company provides efficient, intelligent, flexible and customizable automation solutions to optimize warehousing operations. Dedicated to R&D in autonomous case-handling robotic (ACR) system, HAI ROBOTICS possesses a number ofpatents. As pioneers in ACR, HAI ROBOTICS successfully launched the first ACR system HAIPICK in 2015. The company has been perfecting its products continuously with its expanding customer portfolio ever since. With HAIPICK, warehouse automation can be deployed within one week. HAIPICK has increased warehouse operation efficiency by 3-4 times, and storage density by 80%-130% for clients including DHL Supply Chain, BEST Supply Chain and Phillips etc.. | Series C / Sep 21, 2021 | ||
| It is a leading biotech company focused on immunology-related therapeutic areas. | $100M / Series C / Jun 01, 2021 | ||
| See all 40 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does VMS Asset Management invest in?
VMS Asset Management invests primarily in Biotechnology, Health Care and Big Data startups, most often at Series C and Series A stage. Most of the 40 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does VMS Asset Management invest in?
VMS Asset Management typically joins rounds of $8M–$1.5B at Series A, $16M–$80M at Series B and $15M–$100M at Series C. These are whole funding-round sizes, not VMS Asset Management's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds VMS Asset Management took part in.
How do I contact VMS Asset Management?
Public channels for VMS Asset Management include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at VMS Asset Management?
The team at VMS Asset Management includes Wu Zhaowei (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
